Clinical Trial Update: C1-INH Compared to Placebo at the Time of Prodromal Symptoms for Hereditary Angioedema (HAE) Exacerbation [Phase 4]

View source ↗

Summary

Phase 4 trial comparing C1 esterase inhibitor to placebo at prodromal symptoms for hereditary angioedema has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• C1-esterase inhibitor

Snippet

Sponsor: Penn State University | Conditions: Hereditary Angioedema | Phase 4 | Status: WITHDRAWN